HK Stock Movement | ADICON HOLDINGS (09860) Rises Over 8% in Early Trading as AI Giants Vie for AI Healthcare Market; Domestic AI Medical Applications Lead in Practice

Stock News
01/12

ADICON HOLDINGS (09860) surged more than 8% during the morning session. As of the time of writing, the stock was up 6.38%, trading at HK$5, with a turnover of HK$5.2193 million. On the news front, according to media reports, OpenAI announced the launch of ChatGPT Health, a model integrated into ChatGPT that serves as a "dedicated, separate space for health-related conversations with ChatGPT." It can connect to electronic medical records and various health applications, generating responses that incorporate users' health information and personal context. Just days after OpenAI announced new tools for clinicians, Anthropic stated on Sunday local time that its chatbot, Claude, will introduce new healthcare services compliant with the HIPAA standard, allowing hospitals, healthcare providers, and consumers to use the service for handling protected health data. Anthropic has also integrated scientific databases into its product and enhanced its capabilities for biological research. It is understood that currently, domestic AI medical application practices are already at the forefront. Ant Group's "A-Fu" App saw its monthly active users quickly double to 30 million after a brand upgrade, with daily inquiries exceeding 10 million. The key to its success lies in integrating a full chain of services from health consultation to online appointment booking and medical insurance payments, effectively reaching lower-tier markets. Previously, ADICON HOLDINGS launched the "Ai Xiao Yi" intelligent assistant for doctors, providing one-stop services including test recommendations, intelligent consultation, report interpretation, and professional Q&A. Concurrently, it is deploying the medical AI large model "Wen Yi" to strengthen clinical decision support and multi-modal data integration capabilities.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10